Buffers Benefit from Single-Use Systems
Single-use systems offer a solution to the challenges inherent in buffer preparation, which can be the cause of bottlenecking in bioprocessing.
Because the manufacturing of biotherapeutics requires large volumes of process liquids, buffer preparation is an important aspect of large-scale biomanufacturing. To address the challenges of buffer preparation and ease bottlenecking, MilliporeSigma developed the BioContinuum Buffer Delivery Platform, a new component to its BioContinuum Platform. BioPharm Internationalspoke with Andrew Bulpin, head of process solutions at MilliporeSigma, about what the company’s buffer delivery platform entails, such as single-use components, and the benefits it offers to biomanufacturers.
Read this article in BioPharm International's Single-Use Systems 2019 eBook.
Article Details
BioPharm International
eBook: Single-Use Systems 2019
Vol. 32
June 2019
Pages: 14–17
Citation
When referring to this article, please cite it as F. Mirasol, "Buffers Benefit from Single-Use Systems," BioPharm International Single-Use SystemseBook (June 2019).
Novel Modalities Spur Shift in Outsourcing Processes and Partnerships
May 8th 2025While a one-stop shop still has its advantages, sponsor companies and CDMOs are starting to see each other not as transactional relationships, but true partners with a common goal of getting drugs to patients faster.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
